JAK1 and neoplasm: The mechanisms of acquired resistance are categorized into three types: (1) Tumor-associated gene mutations: For example, JAK1/2 loss-of-function mutation in tumor cells can disrupt the interferon-gamma (IFN-γ) signaling pathway terminal, reducing immune cell activation and infiltration [23].